Fluent Financial, LLC Amgen Inc Transaction History

Fluent Financial, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $2.36 Million - $2.61 Million	-10,764 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $4.52 Million - $5.17 Million	-22,736 Reduced 67.87%	10,764 $2.42 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $1.12 Million - $1.32 Million	5,290 Added 18.75%	33,500 $7.12 Million
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $116,089 - $128,792	-497 Reduced 1.73%	28,210 $6.88 Million
Q4 2020 Jan 22, 2021	BUY	$216.38 - $257.67 $918,316 - $1.09 Million	4,244 Added 17.35%	28,707 $6.6 Million
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $254,125 - $282,608	1,083 Added 4.63%	24,463 $6.22 Million
Q2 2020 Jul 15, 2020	BUY	$197.81 - $242.74 $59,145 - $72,579	299 Added 1.3%	23,380 $5.51 Million
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $892,064 - $1.18 Million	4,895 Added 26.92%	23,081 $4.68 Million
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $3.44 Million - $4.42 Million	18,186 New	18,186 $4.38 Million
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $1.07 Million - $1.28 Million	-6,159 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $1.03 Million - $1.2 Million	6,159 New	6,159 $1.14 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $521,563 - $585,827	-3,141 Closed	0 $0
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $358,852 - $419,364	-2,118 Reduced 40.27%	3,141 $540,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $887,666 - $991,794	5,259	5,259 $950,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Fluent Financial, LLC with notifications on news.